Africa Healthcare Market: How UK Medical and Healthcare Brands Access the Continent's Growing Sector
Africa's healthcare market was estimated at $40-50 billion in 2024 and growing at 8-10% annually. UK medical device, diagnostics, pharmaceutical, and healthcare equipment brands have significant opportunities — particularly in private healthcare, hospital equipment, and primary care strengthening programmes.
Africa's healthcare market context#
Africa's healthcare market is one of the fastest-growing sectors on the continent — driven by rising per-capita incomes, urbanisation (which shifts healthcare-seeking behaviour toward formal providers), rapid population growth (Africa's population is projected to double to 2.5 billion by 2050), and increasing government investment in healthcare infrastructure. The market encompasses public sector procurement (government hospitals and health facilities), private sector healthcare (private hospitals, clinics, pharmacies, and diagnostics laboratories), NGO and development organisation procurement, and the growing consumer health and wellness segment. UK healthcare brands — medical devices, diagnostics, pharmaceuticals, hospital equipment, and health technology — have significant opportunities across all four segments.
The private healthcare opportunity#
Africa's private healthcare sector is growing rapidly — driven by the inability of public health systems to keep pace with population growth and the rising willingness of urban middle-class consumers to pay for quality private care. Major private hospital groups with significant Africa presence include Mediclinic (South Africa, UAE, Switzerland), Life Healthcare (South Africa), Netcare (South Africa), Aga Khan Health Services (East Africa), and Avenue Healthcare (Kenya). These private hospital groups are sophisticated institutional buyers — they procurement through centralised purchasing departments, have international quality standards, and are receptive to UK-origin medical equipment and supplies as quality signals. For UK medical equipment brands, a direct sales relationship with the procurement departments of major private hospital groups is the most efficient market entry approach.
Public sector healthcare procurement in Africa#
Public healthcare procurement in African countries typically occurs through: direct government tender processes (for large capital equipment purchases), pooled procurement mechanisms (various development-donor-supported pooled purchasing programmes for essential medicines and consumables), and national medical stores (government bodies that manage procurement and distribution of essential medicines and medical supplies). The Kenya Medical Supplies Authority (KEMSA), the Ghana Health Service, and equivalent bodies in other countries are the primary procurement entities. UK brands supplying to public sector healthcare must typically be registered with the relevant national pharmaceutical or medical device regulatory authority — a process that can take 6-18 months in some markets.
UK Government and development finance in Africa healthcare#
The UK Government plays a significant role in Africa's healthcare sector — through direct bilateral aid (FCDO-funded health programmes), UK Aid-funded multilateral programmes (WHO, UNICEF, Gavi vaccine alliance), and British International Investment (BII, formerly CDC) equity investment in private healthcare facilities. For UK healthcare brands, these UK Government-linked programmes create commercial opportunities: donor-funded procurement often specifies quality standards that favour UK and European suppliers, FCDO-funded capacity-building programmes create demand for training equipment and simulation products, and BII-backed private hospitals provide an introduction and endorsement that can open procurement relationships.
Regulatory requirements for Africa healthcare#
Africa's medical device and pharmaceutical regulatory landscape is fragmented — each country has its own regulatory authority with different registration requirements, timelines, and fee structures. The African Medicines Agency (AMA) — launched formally in 2021 — is working toward continental harmonisation but full harmonisation is years away. Key regulatory authorities: SAHPRA (South Africa Health Products Regulatory Authority) — the most rigorous and internationally recognised in Sub-Saharan Africa, whose approval is often used as the basis for other countries' regulatory decisions. KEBS and KEPHIS (Kenya) — Kenya's regulatory framework for medical devices. NAFDAC (Nigeria) — Nigeria's pharmaceutical and device regulatory authority, known for thorough review processes. UK CE marking is recognised by SAHPRA and several other African regulatory authorities — products with CE or UKCA marking are well-positioned for Africa regulatory registration.
People also ask
How do UK medical device companies enter African markets?
UK medical device companies typically enter African markets through: direct sales relationships with private hospital group procurement departments (starting with South Africa's Mediclinic, Life Healthcare, or Netcare), registration with national regulatory authorities (beginning with SAHPRA for South Africa), and partnerships with in-country medical device distributors who hold regulatory approvals and manage customer relationships.
What is the regulatory process for medical devices in Africa?
Each African country has its own medical device regulatory authority and registration process. SAHPRA (South Africa) is the most rigorous and internationally respected — products registered with SAHPRA are well-positioned for recognition by other African regulatory authorities. UK CE or UKCA marking significantly speeds up regulatory approval in many African markets.
Model your Africa healthcare market strategy with AskBiz
AskBiz helps you calculate the commercial opportunity and market entry cost for Africa's healthcare sector. Free to start.
Start free — no credit card required →